269 related articles for article (PubMed ID: 14987449)
1. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.
Baptista MJ; Cookson MR; Miller DW
Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449
[TBL] [Abstract][Full Text] [Related]
2. The biochemistry of Parkinson's disease.
Cookson MR
Annu Rev Biochem; 2005; 74():29-52. PubMed ID: 15952880
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: alpha-synuclein and parkin in protein aggregation and the reversal of unfolded protein stress.
Jakobsen LD; Jensen PH
Methods Mol Biol; 2003; 232():57-66. PubMed ID: 12840539
[No Abstract] [Full Text] [Related]
5. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
[TBL] [Abstract][Full Text] [Related]
7. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
Corti O; Brice A
J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
9. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
[TBL] [Abstract][Full Text] [Related]
10. New aspects of genetic contributions to Parkinson's disease.
Hofer A; Gasser T
J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
[TBL] [Abstract][Full Text] [Related]
11. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.
Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR
Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618
[TBL] [Abstract][Full Text] [Related]
12. Familial Parkinson's disease. Alpha-synuclein and parkin.
Mizuno Y; Hattori N; Kitada T; Matsumine H; Mori H; Shimura H; Kubo S; Kobayashi H; Asakawa S; Minoshima S; Shimizu N
Adv Neurol; 2001; 86():13-21. PubMed ID: 11553970
[TBL] [Abstract][Full Text] [Related]
13. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
[TBL] [Abstract][Full Text] [Related]
14. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in research on Parkinson disease: synuclein and parkin.
Burke RE
Neurologist; 2004 Mar; 10(2):75-81. PubMed ID: 14998437
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways of neurodegeneration in Parkinson's disease.
Dawson TM; Dawson VL
Science; 2003 Oct; 302(5646):819-22. PubMed ID: 14593166
[TBL] [Abstract][Full Text] [Related]
17. alpha-Synuclein and parkin: coming together of pieces in puzzle of Parkinson's disease.
Burke RE
Lancet; 2001 Nov; 358(9293):1567-8. PubMed ID: 11716878
[No Abstract] [Full Text] [Related]
18. Pathological proteins in Parkinson's disease: focus on the proteasome.
Snyder H; Wolozin B
J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
[TBL] [Abstract][Full Text] [Related]
19. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
Haywood AF; Staveley BE
BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
[TBL] [Abstract][Full Text] [Related]
20. Genetics of Parkinson's disease.
Polymeropoulos MH
Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
